Corpus Intelligence IC Memo — CENTRAL PENINSULA GENERAL HOSPITAL 2026-04-26 06:36 UTC
IC Memo — CENTRAL PENINSULA GENERAL HOSPITAL
Investment Committee Memorandum | AK | 49 beds | Grade B | EBITDA uplift $18.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CENTRAL PENINSULA GENERAL HOSPITAL

CCN 020024 | KENAI PENINSULA BOROUGH, AK | 49 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

CENTRAL PENINSULA GENERAL HOSPITAL is a 49-bed suburban community hospital in KENAI PENINSULA BOROUGH, AK with $255.1M in net patient revenue and a 5.5% operating margin. The hospital serves a payer mix of 48.7% Medicare, 20.8% Medicaid, and 30.6% commercial.

Thesis: Turnaround. Our ML models identify $18.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.5% to 12.9% (+736bps).

Net Revenue HCRIS$255.1M
Current EBITDA COMPUTED$14.1M
Operating Margin COMPUTED5.5%
Occupancy HCRIS78.7%
Revenue / Bed COMPUTED$5.2M
Net-to-Gross HCRIS42.8%
Distress Probability ML41.9%

2. Market Context & Competitive Position

24
AK Hospitals
-2.1%
State Median Margin
2672
Comparable Hospitals

AK has 24 Medicare-certified hospitals with a median operating margin of -2.1%. The target's margin of 5.5% places it above the state median. Among 2672 size-comparable peers (24-98 beds), the median margin is -4.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-98), prioritizing same-state peers. 2672 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CENTRAL PENINSULA GENERAL HOSP (Target)AK49$255.1M5.5%
DANA-FARBER CANCER INSTITUTEMA30$1.88B-35.1%
MIDWESTERN REGIONAL MEDICAL CEIL73$1.38B80.5%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
RANCHO LOS AMIGOS NATL.REHAB.CCA83$512.6M41.9%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%
ST. JOSEPHS COMM. HOSPT.WI70$436.8M66.1%
LAKEVIEW MEMORIALMN68$411.9M60.9%
MOUNTAIN VIEW HOSPITALID43$382.5M8.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $18.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.4M+210bp18mo
Cost to Collect4.5%2.5%$5.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.1M+122bp9mo
Clean Claim Rate88.0%96.0%$163K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.4M
Cost to Collect
$5.1M
Denial Rate Reduction
$5.1M
A/R Days Reduction
$3.1M
Clean Claim Rate
$163K
Total EBITDA Uplift$18.8M
Current EBITDA$14.1M
+ RCM Uplift+$18.8M
Pro Forma EBITDA$32.9M
Current Margin5.5%
Pro Forma Margin12.9%
WC Released (1x)$9.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$21.8M$281.1M12.91x66.8%
Base (11x exit)10.0x11.0x$21.8M$316.3M14.53x70.8%
Bull Case9.0x11.0x$19.6M$385.4M19.67x81.5%
Bull (12x exit)9.0x12.0x$19.6M$426.2M21.75x85.1%
Bear Case11.0x10.0x$23.9M$180.2M7.52x49.7%
Bear (11x exit)11.0x11.0x$23.9M$206.0M8.60x53.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 2672 hospitals with 24-98 beds
  • Same-state prioritization (n=7)
  • Comp margins: P25=-16.7% / P50=-4.1% / P75=7.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.